H

    Humana Inc (HUM)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $383.50
    -2.04 (-0.53%)

    Market Cap: $46.30B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +5.54%
    Streak
    6 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.02
    Range$-1.29 - $-0.60
    22 analysts
    EPS RevisionsNo revisions (7d)
    5
    15
    30d
    EPS Estimate Drift
    90d ago$-0.06+93.8%
    60d ago$-0.17+83.3%
    30d ago$-0.17+83.3%
    7d ago$-0.99+2.5%
    Current$-1.02
    Revenue Consensus
    $40.9B
    Range$40.4B - $41.4B
    17 analysts
    Dec 31, 2026
    EPS Consensus$-7.03
    Range$-7.73 - $-5.63
    26 analysts
    Revenue Consensus
    $41.9B
    Range$40.7B - $44.3B
    20 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-7.03---
    Sep 26EST
    		-$-1.02---
    Jun 26
    		$7.61$6.22+22.35%Beat+21.4%
    Mar 26
    		$10.31$10.20+1.08%Beat-11.0%
    Dec 25
    		$-3.96$-3.99+0.75%Beat-83.3%
    Sep 25
    		$3.24$2.91+11.34%Beat-22.1%
    Jun 25
    		$6.27$5.87+6.81%Beat-9.9%
    Mar 25
    		$11.58$10.07+14.99%Beat+60.2%
    Dec 24
    		$-2.16$-2.12-1.89%Miss-1863.6%
    Sep 24
    		$4.16$3.39+22.71%Beat-46.5%
    Jun 24
    		$6.96$5.86+18.77%Beat-22.1%
    Mar 24
    		$7.23$6.00+20.50%Beat-22.9%
    Dec 23
    		$-0.11N/A-111.96%Miss-106.8%
    Sep 23
    		$7.78$7.17+8.51%Beat+13.1%
    Jun 23
    		$8.94$8.83+1.25%Beat+3.1%
    Mar 23
    		$9.38$9.20+1.96%Beat+16.7%
    Dec 22
    		$1.62$1.46+10.96%Beat+30.6%
    Sep 22
    		$6.88$6.28+9.55%Beat+42.4%
    Jun 22
    		$8.67$7.67+13.04%Beat+25.8%
    Mar 22
    		$8.04$6.80+18.24%Beat+4.8%
    Dec 21
    		$1.24$1.16+6.90%Beat+153.9%
    Sep 21
    		$4.83$4.67+3.43%Beat+56.8%
    Jun 21
    		$6.89$6.84+0.73%Beat-45.1%
    Mar 21
    		$7.67$7.10+8.03%Beat+42.0%
    Dec 20
    		$-2.30$-2.32+0.86%Beat-200.9%
    Sep 20
    		$3.08$2.80+10.00%Beat-38.8%
    Jun 20
    		$12.56$10.12+24.11%Beat+107.6%
    Mar 20
    		$5.40$4.69+15.14%Beat+20.5%
    Dec 19
    		$2.28$2.19+4.11%Beat-14.0%
    Sep 19
    		$5.03$4.57+10.07%Beat+9.8%
    Jun 19
    		$6.05$5.27+14.80%Beat+52.8%
    Mar 19
    		$4.48$4.30+4.19%Beat+33.3%
    Dec 18
    		$2.65$2.53+4.74%Beat+28.6%
    Sep 18
    		$4.58$4.24+8.02%Beat+35.1%
    Jun 18
    		$3.96$3.78+4.76%Beat+13.5%
    Mar 18
    		$3.36$3.20+5.00%Beat+22.2%
    Dec 17
    		$2.06$2.00+3.00%Beat-1.4%
    Sep 17
    		$3.39$3.27+3.67%Beat+6.6%
    Jun 17
    		$3.49$3.06+14.05%Beat-
    Mar 17
    		$2.75$2.63+4.56%Beat-
    Dec 16
    		$2.09$2.06+1.46%Beat-
    Sep 16
    		$3.18$3.15+0.95%Beat-

    Dividends

    Dividend Metrics

    Yield0.92%
    Annual/Share$3.54
    Payout Ratio16.74%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+3.97%
    5Y CAGR+7.20%
    View HUM's full dividend history

    Key Metrics

    Valuation
    P/E Ratio22.30EV/EBITDAN/A
    Price/FCF23.63xFCF Yield4.23%
    Profitability
    Profit Margin0.88%Operating Margin3.46%
    ROE6.89%ROIC5.83%
    Financial Health
    Debt/Equity0.74xInterest Coverage3.37x
    Current Ratio1.74xQuick Ratio1.74x
    Trading Statistics
    Beta0.74Avg Volume1.09M
    52-Week High$428.8852-Week Low$161.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$384.87
    SMA 20$381.63
    SMA 50$385.36
    SMA 200$275.36
    EMA 10$385.54
    EMA 20$384.01
    EMA 50$372.50
    EMA 200$304.34

    MACD

    Line: 2.12Signal: 1.77Hist: 0.34

    ADX

    ADX: 16.0+DI: 17.8-DI: 14.5

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down28.0
    PSAR$366.97

    Bollinger Bands

    Upper Band$399.25
    Lower Band$364.01
    %B Position923%(Upper)
    Band Width0.55

    RSI (14-Day)

    Neutral
    50.5

    Momentum Oscillators

    Stoch %K51.4
    Stoch %D62.8
    Williams %R-60.0
    ROC (10d)-0.2%
    Momentum-0.81
    CCI (20d)31.0
    MFI (14d)61.6

    Volatility Measures

    ATR (14d)$12.83(3.3%)
    StdDev (20d)8.81
    Hist Vol32.4%(Moderate)

    Volume Flow

    VWAP$384.70
    OBV69.1M
    AD Line-378.4M
    CMF (20d)-0.013

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio0.9x
    VWMA (20d)$380.50

    Pivot Points

    R3$405.61
    R2$401.47
    R1$393.50
    Pivot Point$389.36
    S1$381.40
    S2$377.26
    S3$369.29

    Advanced Oscillators

    TSI4.69
    Ultimate Osc42.4
    KST-2.57

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$40.87B$39.65B$32.52B$32.65B$32.39B$32.11B$29.21B$29.40B$29.54B$29.61B$26.46B$26.42B
    Cost of Revenue$35.37B$33.71B$28.72B$27.99B$27.57B$26.54B$25.38B$25.12B$25.04B$25.12B$22.78B$21.75B
    Gross Profit$5.50B$5.94B$3.79B$4.66B$4.82B$5.58B$3.83B$4.28B$4.50B$4.49B$3.68B$4.68B
    Operating Expenses$4.14B$4.19B$4.60B$4.26B$3.73B$3.56B$4.38B$3.55B$3.36B$3.25B$4.03B$3.47B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$3.98B$4.02B$4.44B$4.08B$3.55B$3.38B$4.17B$3.34B$3.15B$3.04B$3.83B$3.27B
    Operating Income$1.36B$1.75B$-808,000,000$400.00M$1.10B$2.01B$-543,000,000$728.00M$1.14B$1.24B$-348,000,000$1.21B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$197.00M$193.00M$146.00M$168.00M$157.00M$160.00M$164.00M$169.00M$168.00M$159.00M$146.00M$114.00M
    Income Before Tax$952.00M$1.59B$-1,011,000,000$134.00M$741.00M$1.69B$-862,000,000$651.00M$918.00M$1.01B$-591,000,000$1.10B
    Income Tax Expense$238.00M$395.00M$-249,000,000$-86,000,000$179.00M$406.00M$-216,000,000$155.00M$223.00M$251.00M$-75,000,000$256.00M
    Net Income$693.00M$1.18B$-776,000,000$194.00M$543.00M$1.24B$-683,000,000$480.00M$678.00M$739.00M$-540,000,000$830.00M
    EBITDA$1.34B$1.98B$-671,000,000$506.00M$1.11B$2.07B$-458,000,000$1.06B$1.33B$1.42B$-207,000,000$1.45B
    EBIT$1.15B$1.79B$-865,000,000$302.00M$898.00M$1.85B$-698,000,000$820.00M$1.09B$1.17B$-445,000,000$1.21B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    I Tested One Of Wall Street’s Favorite AI Trades - It Failed

    Travelers Q2 core income $10.04 vs $5.41 consensus, stock +10%; CEO credited AI for a 0.5 percentage-point improvement in underlying loss ratio while expense ratio rose to 29%. Wall Street thesis posits AI cuts SG&A to create EPS torque in low-margin giants - e.g., CVS 0.4% net margin on $402bn revenue, $45bn SG&A, a 3% SG&A cut modeled to lift GAAP EPS $1.36 to $2.17 (60%). GAAP EPS torque is often an artifact of writedowns, not pure operating leverage. Most SG&A is hourly store labor and not addressable by LLMs - Kroger's $28bn OG&A is dominated by store jobs, a 3% cut implies roughly 12,000 roles and multi-year capex, not immediate automated savings. Regulated payers tend to pass admin savings back via bids - Medicaid and Medicare Advantage reprice to observed costs; by contrast loss-ratio gains stick.

    Unknown Author
    •
    8/2/26
    •
    223
    AI Stocks
    Also mentions:
    TRV
    CVS
    KR
    WMT
    UNH

    Health Insurer Stocks: Recent Crash is Likely An Attractive Buffett Style "Fat Pitch" Opportunity

    Monday Jan 27th was "The Monday night massacre" when Medicare announced a 0.7% increase in reimbursement rates for 2026. 5% to 6% was the consensus and health insurance companies fell between 8% and 20% in overnight trading. Only Humana has continued to decline (-26% so far) but Morningstar (and I) agree that even a one year change in reimbursment shouldn't significantly change any fair value PEs or long-term growth rates. UNH and CVS are trading near historical fair value, with UNH offering the best long-term growth potential (3% yield and about 20% CAGR returns over 5 years). ELV is trading at a modest historical discount with management guiding for strong growth despite this Medicare headwind. HUM is trading at 11X earnings, a nearly 50% historical discount with up to 5X return potential in the next 4 to 5 years (Morningstar is even more optimistic). Just remember that the biggest risk is that health insurance inflation (about 300% over 20 years) is becoming a hot button topic for both political parties, so political headline risk like this might become more common. For the medium-term (3 to 5 years) the health insurance industry is likely to see double-digit EPS growth.

    Unknown Author
    •
    1/29/26
    •
    303
    value investing
    Income, Value
    Dividend Growth
    Dividend Investing
    Also mentions:
    ELV
    CVS
    HUM

    3 Ways Your Family Can Thrive In The Age Of AI

    The Age of AI is simultaneously terrifying, thrilling, terrible, delightful, and full of wonders. To keep your family safe, sane, and prosperous requires a humble appreciation that the world is more complex than any human can imagine, and change is only going to keep accelerating. Contradictory facts can (and usually are) true in this complex world, and the details are often the difference between success and failure, between retiring in comfort, in splendor, or not at all. Compassion for those whose lived experiences are different than the statistical data is important to follow the excellent advice of "Act justly, love mercy, and walk humbly" At the same time, only discplined financial scientist investors, whose facts and reasoning are right, are going to thrive, and help their families thrive by accruing assets, which are the currency of the future. Asset based living is what will seperate those who live in a Star Trek utopia, and those who live in a Westeros like feudal society where they feel trapped and desperate. I am so excited to be able to help build a company that can guide wonderful people through this terrible yet delightfully wonderous period of history! It's an honor to be on this journey with all of you right now! NVDA, HUM, and BAM are the stocks ZEUS bought today during the silly freakout over the Fed MAYBE not cutting in Dec. Earnings growth is 15%, the economy is strong, and Olive Garden awaits😉🤣😂🤗

    Unknown Author
    •
    11/13/25
    •
    522
    economy
    earnings
    recession
    Dividend Investing
    Also mentions:
    HUM
    BAM

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -100.0%
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Redwood Investment Management LLC Invests $1.17 Million in HCA Healthcare, Inc. $HCA

    Redwood Investment Management LLC recently acquired 3,010 shares of HCA Healthcare, valued at approximately $1.17 million, during the second quarter. HCA Healthcare exceeded analyst expectations with $7.59 EPS and $20.23 billion in revenue, also declaring a quarterly dividend of $0.78. Analysts have a "Moderate Buy" consensus for HCA Healthcare, with an average price target of $462.64.

    MarketBeat•8/27/26•
    Neutral

    Summit Street Capital Management LLC Makes New Investment in Humana Inc. $HUM

    Summit Street Capital Management LLC has made a new investment in Humana Inc. (NYSE:HUM), purchasing 91,449 shares valued at approximately $36.3 million, making it their third-largest portfolio holding. Other institutional investors have also increased their positions in Humana, with institutional ownership now at 92.38%. Despite a mixed analyst consensus of "Hold" and an average price target of $403.91, Humana recently surpassed quarterly earnings and revenue expectations.

    MarketBeat•8/27/26•
    Bullish

    Permanens Capital L.P. Invests $1.55 Million in Humana Inc. $HUM

    Permanens Capital L.P. recently invested $1.55 million in Humana Inc. by purchasing 3,884 shares, becoming one of many institutional investors holding 92.38% of the company's stock. Despite mixed analyst ratings, Humana exceeded quarterly earnings expectations with $7.61 EPS and $40.89 billion in revenue, a 26.2% year-over-year increase. The stock currently holds a "Hold" consensus rating with a target price of $403.91.

    MarketBeat•8/27/26•
    Somewhat-Bullish

    Primecap Management Co. CA Purchases Shares of 9,250 Humana Inc. $HUM

    Primecap Management Co. CA recently acquired 9,250 shares of Humana Inc. (NYSE:HUM) during the second quarter, a new position valued at approximately $3.7 million. Institutional investors and hedge funds hold a significant 92.38% of Humana's outstanding stock. Despite a mixed analyst sentiment, Humana surpassed its quarterly earnings estimates, reporting $7.61 per share against a $7.27 consensus, with a revenue increase of 26.2% year-over-year.

    MarketBeat•8/27/26•
    Somewhat-Bullish

    Jupiter Topco LLC Makes New $84.35 Million Investment in Humana Inc. $HUM

    Jupiter Topco LLC has made a significant new investment of $84.35 million in Humana Inc. by acquiring 212,346 shares. This acquisition gives Jupiter Topco LLC a 0.18% stake in the insurance provider, highlighting continued institutional interest in Humana. The investment follows Humana's strong financial performance, including exceeding quarterly EPS and revenue expectations, and occurs amidst mixed but generally positive analyst sentiment, with several firms upgrading the stock.

    MarketBeat•8/27/26•
    Somewhat-Bullish

    Frequently Asked Questions About HUM

    What is HUM's current dividend yield?
    Humana Inc (HUM) has a current dividend yield of 0.92%.
    Does HUM pay dividends?
    Yes, Humana Inc pays dividends with a current yield of 0.92%.
    What is HUM's P/E ratio?
    Humana Inc has a price-to-earnings (P/E) ratio of 22.30.
    What is HUM's market cap?
    Humana Inc (HUM) has a market capitalization of $46.30B with a current stock price of $383.50.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In